KBC Group’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.6M Sell
50,566
-60,936
-55% -$15.3M 0.03% 338
2025
Q4
$31.7M Buy
111,502
+49,757
+81% +$15.6M 0.07% 208
2025
Q3
$19.1M Buy
61,745
+29,857
+94% +$9.35M 0.05% 271
2025
Q2
$10M Buy
31,888
+17,176
+117% +$4.96M 0.03% 360
2025
Q1
$3.86M Sell
14,712
-3,168
-18% -$857K 0.01% 492
2024
Q4
$4.67M Sell
17,880
-7,660
-30% -$1.93M 0.01% 500
2024
Q3
$5.95M Buy
25,540
+16,161
+172% +$3.32M 0.02% 447
2024
Q2
$1.89M Buy
9,379
+85
+0.9% +$15.3K 0.01% 593
2024
Q1
$1.59M Sell
9,294
-362
-4% -$67.5K 0.01% 618
2023
Q4
$2.1M Sell
9,656
-1,284
-12% -$220K 0.01% 601
2023
Q3
$1.75M Sell
10,940
-2,462
-18% -$551K 0.01% 605
2023
Q2
$3.87M Sell
13,402
-21,414
-62% -$6.5M 0.02% 498
2023
Q1
$11.1M Buy
34,816
+30,114
+640% +$8.93M 0.05% 329
2022
Q4
$1.38M Buy
4,702
+3
+0.1% +$827 0.01% 661
2022
Q3
$1.08M Sell
4,699
-705
-13% -$177K 0.01% 656
2022
Q2
$1.18M Buy
5,404
+131
+2% +$29.8K 0.01% 638
2022
Q1
$1.41M Sell
5,273
-582
-10% -$143K 0.01% 637
2021
Q4
$1.56M Sell
5,855
-3,655
-38% -$1.06M 0.01% 646
2021
Q3
$2.7M Sell
9,510
-9,510
-50% -$2.71M 0.01% 603
2021
Q2
$5.22M Buy
19,020
+384
+2% +$104K 0.01% 613
2021
Q1
$4.86M Buy
18,636
+584
+3% +$156K 0.01% 613
2020
Q4
$25.4M Sell
18,052
-33,624
-65% -$8.34M 0.01% 607
2020
Q3
$12.2M Buy
51,676
+11,106
+27% +$2.34M 0.04% 377
2020
Q2
$7.88M Buy
40,570
+31,477
+346% +$6.02M 0.03% 434
2020
Q1
$1.51M Buy
9,093
+4,856
+115% +$887K 0.01% 614
2019
Q4
$725K Buy
+4,237
New +$706K ﹤0.01% 1004

Other funds holding PODD

KBC Group's PODD Position: Q1 2026 in Review

KBC Group reduced its Insulet (PODD) stake by 55% in Q1 2026, selling an estimated $15.3M and leaving 50,566 shares worth $10.6M. The position accounts for 0.03% of the portfolio, ranked #338.

KBC Group first reported a position in PODD in Q4 2019 and has held it in 26 quarters since. The position peaked at $31.7M in Q4 2025. 785 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • KBC Group held 50,566 shares of Insulet worth $10.6M as of Q1 2026.
  • KBC Group sold 60,936 Insulet shares in Q1 2026, an estimated $15.3M.
  • Insulet made up 0.03% of KBC Group's portfolio in Q1 2026, its #338 holding.
  • KBC Group first reported a position in Insulet in Q4 2019 and has held it in 26 quarters since.
  • KBC Group's Insulet position peaked at $31.7M in Q4 2025.
  • 785 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.